Asia - Australia - Austria - Austria, Germany, Switzerland - Belgium - Brazil - Brunei Darussalam - Canada - China - Colombia - Denmark - Europe - Europe, United States - France - Germany - Gulf Cooperation Council - High-income countries - Hong Kong - Indonesia - International - Ireland - Italy - Japan - Low and middle income countries - Netherlands - New Zealand - Norway - Puerto Rico - Republic of Korea - Saudi Arabia - Singapore - South Africa - Spain - Sri Lanka - Sweden - Switzerland - Syria - Taiwan - Thailand - United Kingdom - United States - WHO - {Related topics}

Asia

• BMC Cancer
  • Survival rate of ovarian cancer in Asian countries: a systematic review and meta-analysis [2023]

• European Society for Medical Oncology
  • Pan-Asia adapted ESMO Clinical Practice Guideline for the management of patients with newly diagnosed and relapsed epithelial ovarian cancer [2025]

Australia

• Australian Institute of Health and Welfare
  • Improving the understanding of ovarian cancer statistics

• Australian Journal of General Practice
  • Advances in epithelial ovarian cancer [2020]

• Cancer Australia
  • Ovarian cancer statistics in Australia
  • Ovarian cancer guidelines

• Gynecologic Oncology
  • Perioperative outcomes after interval cytoreductive surgery and primary cytoreductive surgery for advanced epithelial ovarian cancer in Australia: A National Gynae-Oncology Registry (NGOR) study [2025]

• Journal of Geriatric Oncology
  • Real-world ovarian cancer care and its survival impact on older adults: An observational study from the Australian National Gynae-Oncology Registry (NGOR) [2025]

Austria

• Wiener klinische Wochenschrift
  • Austria-based real-world data on bevacizumab in newly diagnosed epithelial ovarian cancer [2022]
  • AGO Austria recommendations for genetic testing of patients with ovarian cancer [2015]

Austria, Germany, Switzerland

• Archives of Gynecology and Obstetrics
  • Intergroup-statement: statement of the german ovarian cancer commission, the North-Eastern German Society of gynecological Oncology (NOGGO), AGO Austria and AGO Swiss regarding the use of homologous repair deficiency (HRD) assays in advanced ovarian cancer [2025]
  • Intergroup statement: opportunistic salpingectomy-molecular pathology, clinical outcomes and implications for practice (German Ovarian Cancer Commission, the North-Eastern German Society of Gynecologic Oncology (NOGGO), AGO Austria and AGO Swiss) [2025]

Belgium

• Facts, Views & Vision in ObGyn
  • The rationale of opportunistic bilateral salpingectomies (OBS) during benign gynaecological and obstetric surgery: a consensus text of the Flemish Society of Obstetrics and Gynaecology (VVOG) [2019]

• PLoS ONE
  • First- and second-line bevacizumab in ovarian cancer: A Belgian cost-utility analysis [2018]

Brazil

• Journal of Surgical Oncology
  • Surgery in Ovarian Cancer-Brazilian Society of Surgical Oncology Consensus [2025]

• Revista da Associação Médica Brasileira
  • Relapsed ovarian cancer - diagnosis using 18F-FDG PET/CT [2019]

Brunei Darussalam

• Asian Pacific Journal of Cancer Prevention
  • Incidence, Mortality and Survival Analysis of Epithelial Ovarian Cancer in Brunei Darussalam [2022]

Canada

• BC Cancer Agency
  • Ovary – Non-Epithelial Carcinoma
  • Ovary - Epithelial Carcinoma

• Canada's Drug Agency
  • Bevacizumab for Recurrent Platinum-Sensitive Ovarian Cancer [2023]

• Canadian Cancer Society
  • Ovarian cancer statistics
  • Ovarian cancer

• CMAJ
  • Management of ovarian cancer risk in women with BRCA1/2 pathogenic variants [2019]

• Current Oncology
  • Systemic therapy for recurrent epithelial ovarian cancer: a clinical practice guideline [2017]

• Gynecologic Oncology
  • Spatial Analysis of Adherence to Treatment Guidelines for Advanced-Stage Ovarian Cancer and the Impact of Race and Socioeconomic Status [2014]

• Journal of Medical Genetics
  • Practice guidelines for BRCA1/2 tumour testing in ovarian cancer [2022]

• Ontario Health
  • Homologous Recombination Deficiency Testing to Inform Patient Decisions About Niraparib Maintenance Therapy for High-Grade Serous or Endometrioid Epithelial Ovarian Cancer: A Health Technology Assessment [2023]
  • Adjuvant Care for Stage I Ovarian Cancer [2022]
  • Systemic Therapy for Recurrent Epithelial Ovarian Cancer [2017]
  • Ovarian Cancer Pathway Map

• Society of Gynecologic Oncology of Canada
  • Consensus Statement from the Society of Gynecologic Oncology of Canada on Folate Receptor a Testing in Ovarian Cancer [2026]

China

• BMC Women's Health
  • Incidence of different histologic subtype of ovarian cancer in China: a population-based cancer registry study [2025]

• Frontiers in Public Health
  • Configurational analysis of ovarian cancer incidence in 30 provinces of China and its policy implications: a fuzzy-set qualitative comparative analysis approach [2024]

• Journal of Ovarian Research
  • Trends in incidence and mortality for ovarian cancer in China from 1990 to 2019 and its forecasted levels in 30 years [2023]

Colombia

• Revista Colombiana de Obstetricia y Ginecología
  • Expert consensus: Profiling and management of advanced or metastatic epithelial ovarian cancer [2024]

Denmark

• Gynecologic Oncology
  • Incidence, treatment, and survival trends in older versus younger women with epithelial ovarian cancer from 2005 to 2018: A nationwide Danish study [2022]

• International Journal of Cancer
  • Risk of nonovarian cancer in a nationwide-based study of nearly 5000 women with borderline ovarian tumors in Denmark [2023]
  • Pregnancy duration and ovarian cancer risk: A 50-year nationwide cohort study [2022]

• Journal of Geriatric Oncology
  • Impact of surgery and chemotherapy timing on outcomes in older versus younger epithelial ovarian cancer patients: A nationwide Danish cohort study [2023]

Europe

• Annals of Oncology
  • European experts consensus: BRCA/homologous recombination deficiency testing in first-line ovarian cancer [2022]

• British Journal of Cancer
  • An epidemiologic risk prediction model for ovarian cancer in Europe: the EPIC study [2015]

• European Society for Medical Oncology
  • Newly diagnosed and relapsed epithelial ovarian cancer: ESMO Clinical Practice Guideline for diagnosis, treatment and follow-up [2023]
  • eUpdate – Newly Diagnosed Epithelial Ovarian Carcinoma Treatment Recommendations [2021]
  • ESMO recommendations on predictive biomarker testing for homologous recombination deficiency and PARP inhibitor benefit in ovarian cancer [2020]
  • ESMO-ESGO consensus conference recommendations on ovarian cancer: pathology and molecular biology, early and advanced stages, borderline tumours and recurrent disease [2019]
  • Non-epithelial ovarian cancer: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up [2018]

• European Society of Gastrointestinal and Abdominal Radiology
  • Imaging of peritoneal metastases of ovarian and colorectal cancer: joint recommendations of ESGAR, ESUR, PSOGI, and EANM [2024]

• European Society of Gynaecological Oncology
  • ESGO-ESMO-ESP consensus conference recommendations on ovarian cancer: pathology and molecular biology and early, advanced and recurrent disease [2024]
  • Non-Epithelial Ovarian Cancers in Adolescents and Young Adults [2019]
  • Ovarian cancer surgery [2017]
  • ESGO Advanced (stage III-IV) Ovarian Cancer Surgery Quality Indicators [2016]

• European Society of Urogenital Radiology
  • Ovarian cancer staging and follow-up: updated guidelines from the European Society of Urogenital Radiology female pelvic imaging working group [2025]
  • ESR Essentials: characterisation and staging of adnexal masses with MRI and CT-practice recommendations by ESUR [2024]

• International Journal of Gynecological Cancer
  • Clinical Use of Cancer Biomarkers in Epithelial Ovarian Cancer [2016]

• Seminars in Oncology
  • Guidance Statement On BRCA1/2 Tumor Testing in Ovarian Cancer Patients [2017]

Europe, United States

• BJS Open
  • Ovarian cancer risk reduction by salpingectomy during non-gynaecological surgery: scoping review [2024]

• RöFo
  • Ovarian Cancer Screening: Recommendations and Future Prospects [2025]

• Society of Abdominal Radiology
  • Ovarian cancer reporting lexicon for computed tomography (CT) and magnetic resonance (MR) imaging developed by the SAR Uterine and Ovarian Cancer Disease-Focused Panel and the ESUR Female Pelvic Imaging Working Group [2022]

France

• American Journal of Obstetrics & Gynecology
  • Survival outcomes of primary vs interval cytoreductive surgery for International Federation of Gynecology and Obstetrics stage IV ovarian cancer: a nationwide population-based target trial emulation [2025]

• Annals of Surgical Oncology
  • Status of Surgical Management of Borderline Ovarian Tumors in France: are Recommendations Being Followed? Multicentric French Study by the FRANCOGYN Group [2021]

• Bulletin du Cancer
  • Results of a National French Survey on use of KELIM model for management of patients with advanced stage epithelial ovarian cancer (SFOG Campus) [2025]

• Cancers
  • Multi-Disciplinary Care Planning of Ovarian Cancer in Older Patients: General Statement—A Position Paper from SOFOG-GINECO-FRANCOGYN-SFPO [2022]

• Collège National des Gynécologues et Obstétriciens Français
  • Ovarian carcinoma in patients aged >=80 years: A retrospective multicenter study of management and survival in the FRANCOGYN population [2025]
  • Initial management of epithelial ovarian cancer cases [2019]

• Gynecologic Oncology
  • Optimal timing of interval debulking surgery for advanced epithelial ovarian cancer: A retrospective study from the ESME national cohort [2022]

• Journal of Clinical Medicine
  • Results of a 2021 French National Survey on Management of Patients with Advanced Stage Epithelial Ovarian Cancer [2021]

Germany

• Institute for Quality and Efficiency in Health Care
  • Rucaparib (ovarian cancer; maintenance treatment) - Benefit assessment according to §35a Social Code Book V [2019]

• International Journal of Gynecological Cancer
  • Ovarian cancer survival in Germany: a nationwide analysis by stage and histotype [2026]

• PLoS Medicine
  • Ovarian cancer prevention through opportunistic salpingectomy during abdominal surgeries: A cost-effectiveness modeling study [2025]

• Robert Koch Institute
  • Ovarian cancer

• Women's Health
  • Ovarian cancer surgery in Germany: An analysis of the nationwide hospital file 2005-2015 [2022]

• World Journal of Surgical Oncology
  • Hepatic resection for ovarian cancer in Germany: a nationwide epidemiological study based on DRG (diagnosis-related groups) data (2020-2024) [2025]

Gulf Cooperation Council

• BMC Cancer
  • Prevalence of BRCA1 and BRCA2 pathogenic sequence variants in ovarian cancer patients in the Gulf region: the PREDICT study [2021]

High-income countries

• American Journal of Epidemiology
  • Racial and ethnic differences in epithelial ovarian cancer risk: an analysis from the Ovarian Cancer Association Consortium [2024]

Hong Kong

• Acta Obstetricia et Gynecologica Scandinavica
  • Trends and projections of ovarian cancer incidence in Hong Kong: A population-based study [2023]

• Centre for Health Protection
  • Recommendations on Prevention and Screening for Ovarian Cancer For Health Professionals [2018]

Indonesia

• PLoS ONE
  • Investigation of the trends and associated factors of ovarian cancer in Indonesia: A systematic analysis of the Global Burden of Disease study 1990-2021 [2025]

International

• American Journal of Therapeutics
  • Residual Disease Threshold After Primary Surgical Treatment for Advanced Epithelial Ovarian Cancer, Part 1: A Systematic Review and Network Meta-Analysis [2023]

• Annals of Medicine
  • Molecular targeted therapy in combination with chemotherapy for the treatment of platinum-resistant/refractory ovarian cancer (PROC): a systematic review and network meta-analysis [2026]

• Archives of Gynecology and Obstetrics
  • Fertility-sparing surgery upon reproductive and oncologic results in ovarian cancer patients stage I (FIGO): a systematic review [2025]

• Best Practice & Research Clinical Endocrinology & Metabolism
  • Borderline ovarian tumours: A comprehensive review of published evidence [2026]

• BMC Cancer
  • Variation in the initial assessment and investigation for ovarian cancer in symptomatic women: a systematic review of international guidelines [2019]
  • Global patterns and trends in ovarian cancer incidence: age, period and birth cohort analysis [2019]

• BMC Public Health
  • Global burden and trends in ovarian cancer attributable to environmental risks and occupational risks in females aged 20-49 from 1990 to 2021, with projections to 2050: a cross-sectional study [2025]
  • The global burden and associated factors of ovarian cancer in 1990-2019: findings from the Global Burden of Disease Study 2019 [2022]
  • Enhancing ovarian cancer care: a systematic review of guideline adherence and clinical variation [2019]

• BMC Women's Health
  • Diagnostic value of the Risk of Ovarian Malignancy Algorithm (ROMA) index in the detection of ovarian cancer in postmenopausal women: a systematic review and meta-analysis [2025]
  • Analysis of global ovarian cancer disease burden and its changing trend from 1990 to 2021 [2025]

• Cancer Biology & Medicine
  • Epidemiology of ovarian cancer: a review [2017]

• Cancer Medicine
  • Ovarian Cancer and High Body-Mass Index: A Global Burden of Disease Database Study From 1990 to 2021 [2026]

• Cancer Reports
  • Comparing the Effectiveness of Artificial Intelligence Models in Predicting Ovarian Cancer Survival: A Systematic Review [2025]
  • Anthropometric factors and the risk of ovarian cancer: A systematic review and meta-analysis [2022]

• Cancers
  • Worldwide Burden, Risk Factors, and Temporal Trends of Ovarian Cancer: A Global Study [2022]

• Carcinogenesis
  • Urinary biomarkers for the detection of ovarian cancer: a systematic review [2022]
  • Identification of biomarkers for the diagnosis and targets for therapy in patients with clear cell ovarian cancer: a systematic literature review [2022]
  • Joint IARC/NCI International Cancer Seminar Series Report: expert consensus on future directions for ovarian carcinoma research [2021]

• Chinese Clinical Oncology
  • Epidemiology of ovarian cancer [2020]

• Clinical Cancer Research
  • Small Cell Carcinoma of the Ovary, Hypercalcaemic Type – genetics, new treatment targets and current management guidelines [2020]

• Cochrane Database of Systematic Reviews
  • Angiogenesis inhibitors for the treatment of epithelial ovarian cancer [2023]
  • Poly(ADP-ribose) polymerase (PARP) inhibitors for the treatment of ovarian cancer [2022]
  • Menopausal status, ultrasound and biomarker tests in combination for the diagnosis of ovarian cancer in symptomatic women [2022]
  • Impact of residual disease as a prognostic factor for survival in women with advanced epithelial ovarian cancer after primary surgery [2022]

• European Journal of Cancer
  • Homologous recombination deficiency in ovarian cancer: Global expert consensus on testing and a comparison of companion diagnostics [2025]

• European Journal of Cancer Prevention
  • Global, regional, and national burden of ovarian cancer among young women during 1990-2019 [2025]

• European Society of Gynaecological Oncology
  • ESGO/ISUOG/IOTA/ESGE Consensus Statement on pre-operative diagnosis of ovarian tumors [2021]

• Frontiers in Endocrinology
  • The risk of ovarian cancer in hormone replacement therapy users: a systematic review and meta-analysis [2024]

• Frontiers in Public Health
  • Global trend analysis and risk evolution of asbestos-related ovarian cancer: a population-based study and future prediction (1990-2021) [2026]
  • Disease Burden and Attributable Risk Factors of Ovarian Cancer From 1990 to 2017: Findings From the Global Burden of Disease Study 2017 [2021]

• Gynecologic Cancer Intergroup
  • Clinical research in ovarian cancer: consensus recommendations from the Gynecologic Cancer InterGroup [2022]
  • Molecular and clinical predictors of improvement in progression-free survival with maintenance PARP inhibitor therapy in women with platinum-sensitive, recurrent ovarian cancer: A meta-analysis [2021]
  • Assessment of Progression-Free Survival as a Surrogate End Point of Overall Survival in First-Line Treatment of Ovarian Cancer [2020]
  • Update on rare epithelial ovarian cancers: based on the Rare Ovarian Tumors Young Investigator Conference [2017]
  • Harmonising clinical trials within the Gynecologic Cancer InterGroup: consensus and unmet needs from the Fifth Ovarian Cancer Consensus Conference [2017]
  • Fifth Ovarian Cancer Consensus Conference of the Gynecologic Cancer InterGroup: recurrent disease [2017]
  • Fifth Ovarian Cancer Consensus Conference of the Gynecologic Cancer InterGroup: first-line interventions [2017]
  • Fifth Ovarian Cancer Consensus Conference of the Gynecologic Cancer InterGroup (GCIG): clinical trial design for rare ovarian tumours [2017]
  • Survivorship as an element of clinical trials in ovarian cancer [2011]
  • 2004 consensus statements on the management of ovarian cancer: final document of the 3rd International Gynecologic Cancer Intergroup Ovarian Cancer Consensus Conference (GCIG OCCC 2004) [2005]

• International Federation of Gynecology and Obstetrics
  • Worldwide barriers of optimal surgical care provision in advanced ovarian cancer [2025]
  • FIGO position statement on opportunistic salpingectomy as an ovarian cancer prevention strategy [2024]

• International Journal of Cancer
  • The influence of birth cohort and calendar period on global trends in ovarian cancer incidence [2020]

• International Journal of Gynecological Cancer
  • Circulating tumor DNA in the diagnosis of ovarian cancer: a systematic review [2026]
  • Analysis of the global burden of ovarian cancer in adolescents [2025]
  • How long is long enough? An international survey exploring practice variations on the recommended duration of maintenance therapy with PARP inhibitors in patients with platinum sensitive recurrent ovarian cancer and long-term outcomes [2024]
  • Exploring international differences in ovarian cancer treatment: a comparison of clinical practice guidelines and patterns of care [2020]

• International Journal of Hyperthermia
  • Prognostic value and adverse events of cytoreductive surgery with hyperthermic intraperitoneal chemotherapy in primary advanced and platinum-sensitive recurrent epithelial ovarian cancer: a systematic review and meta-analysis [2023]

• International Journal of Molecular Sciences
  • Ovarian Cancer-Epidemiology, Classification, Pathogenesis, Treatment, and Estrogen Receptors' Molecular Backgrounds [2025]

• International Journal of Surgery
  • Global, regional, and national burden of ovarian cancer, 1990-2021, and projections to 2050: a cross-sectional analysis of the Global Burden of Disease Study 2021 [2026]

• International Journal of Women's Health
  • Ovarian cancer in the world: epidemiology and risk factors [2019]

• JCO Global Oncology
  • Global Incidence of Ovarian Cancer According to Histologic Subtype: A Population-Based Cancer Registry Study [2024]

• Journal of Cancer Research and Clinical Oncology
  • Global, regional, and national burden of ovarian cancer in women aged 45 + from 1990 to 2021 and projections for 2050: a systematic analysis based on the 2021 global burden of disease study [2025]

• Journal of Gynecologic Oncology
  • Factors predicting postoperative morbidity after cytoreductive surgery for ovarian cancer: a systematic review and meta-analysis [2022]

• Journal of Medical Internet Research
  • AI-Derived Blood Biomarkers for Ovarian Cancer Diagnosis: Systematic Review and Meta-Analysis [2025]

• Journal of Ovarian Research
  • The clinical characteristics and treatment of ovarian malignant mesoderm mixed tumor: a systematic review [2022]

• Journal of Preventive Medicine and Hygiene
  • Worldwide incidence and mortality of ovarian cancer and Human Development Index (HDI): GLOBOCAN sources and methods 2018 [2021]

• Journal of the National Cancer Institute
  • Lifetime ovulatory years and risk of epithelial ovarian cancer: a multinational pooled analysis [2023]
  • Current Gaps in Ovarian Cancer Epidemiology: The Need for New Population-Based Research [2017]

• Lancet Oncology
  • Ovarian cancer and smoking: individual participant meta-analysis including 28114 women with ovarian cancer from 51 epidemiological studies [2012]

• Medicina
  • Minimally Invasive Surgery in the Management of Advanced Epithelial Ovarian Cancer: A Comprehensive Analysis of Current Evidence and Clinical Applications [2025]

• Medicine
  • Reproductive and oncological outcomes of fertility-sparing surgery in patients with stage I epithelial ovarian cancer: A systematic review and meta-analysis [2022]

• Nature Reviews Cancer
  • Rethinking Ovarian Cancer: Recommendations for Improving Outcomes [2011]

• Przeglad Menopauzalny = Menopause Review
  • Epidemiology and risk factors for ovarian cancer [2023]

• Ultrasound in Obstetrics & Gynecology
  • Diagnostic accuracy of ultrasound models for assessment of ovarian tumors: systematic review and meta-analysis [2026]

• Virchows Archiv
  • Ovarian borderline tumors in the 2014 WHO classification: evolving concepts and diagnostic criteria [2016]

• World Cancer Research Fund
  • Ovarian cancer statistics

• World Journal of Surgical Oncology
  • Oncological outcomes of fertility-sparing surgery versus radical surgery in stage - epithelial ovarian cancer: a systematic review and meta-analysis [2024]
  • Outcome quality standards in advanced ovarian cancer surgery [2020]

Ireland

• Department of Health Ireland
  • Diagnosis and Staging of Patients with Ovarian Cancer

• Ireland's Health Services
  • GP Ovarian Cancer Referral Guideline and Referral Form

Italy

• Critical Reviews in Oncology/Hematology
  • Recommendations for the implementation of BRCA testing in ovarian cancer patients and their relatives [2019]

• Current Oncology
  • The Consistency and Quality of ChatGPT Responses Compared to Clinical Guidelines for Ovarian Cancer: A Delphi Approach [2024]

• Journal of Ovarian Research
  • Current strategies for the targeted treatment of high-grade serous epithelial ovarian cancer and relevance of BRCA mutational status [2019]

Japan

• Cancer Science
  • Japanese nationwide observational multicenter study of tumor BRCA1/2 variant testing in advanced ovarian cancer [2023]

• International Journal of Clinical Oncology
  • Trends in the management and prognosis of mucinous borderline ovarian tumors: analysis of 12,766 cases from the JSOG Gynecologic Tumor Registry (2004-2018) [2026]

Low and middle income countries

• Journal of Cancer Policy
  • Challenges and opportunities in ovarian cancer care: A qualitative study of clinician perspectives from 24 low- and middle-income countries [2025]

Netherlands

• Acta Obstetricia et Gynecologica Scandinavica
  • Stage, treatment and survival of low-grade serous ovarian carcinoma in the Netherlands: A nationwide study [2023]
  • Oncologic outcomes after splenectomy during initial cytoreductive surgery in advanced epithelial ovarian cancer: a nationwide population-based cohort study [2022]

• Familial Cancer
  • Optimizing the detection of hereditary predisposition in women with epithelial ovarian cancer: nationwide implementation of the Tumor-First workflow [2024]

• Fertility and Sterility
  • Incidence of ovarian cancer after bilateral salpingo-oophorectomy in women with histologically proven endometriosis [2022]

• Gynecologic Oncology
  • Survival benefit of platinum-based chemotherapy in non-surgically treated advanced ovarian cancer: A nationwide study [2026]
  • Impact of lymph node dissection and adjuvant chemotherapy on survival of patients with early-stage ovarian cancer: Update of a national cohort study [2025]
  • Textbook outcome as a composite outcome measure to compare hospital performances regarding cytoreductive surgery for ovarian cancer: A nationwide population-based study [2023]

• Gynecologic Oncology Reports
  • Standardizing HIPEC and perioperative care for patients with ovarian cancer in the Netherlands using a Delphi-based consensus [2022]

• International Journal of Cancer
  • Nationwide implementation and evaluation of the Tumor-First workflow for genetic testing in ovarian carcinoma [2025]

New Zealand

• Best Practice Advocacy Centre New Zealand
  • Ovarian cancer – early detection and referral [2023]

Norway

• British Journal of Cancer
  • Ovarian cancer survival by residual disease following cytoreductive surgery: a nationwide study in Norway [2025]

Puerto Rico

• BioMed Research International
  • Ovarian Cancer Screening Practices of Obstetricians and Gynecologists in Puerto Rico [2014]

Republic of Korea

• Cancer Medicine
  • Stratifying the risk of ovarian cancer incidence by histologic subtypes in the Korean Epithelial Ovarian Cancer Study (Ko-EVE) [2023]

• Cancer Science
  • Prevalence and clinical characterization of BRCA1 and BRCA2 mutations in Korean patients with epithelial ovarian cancer [2021]

• ClinicoEconomics and Outcomes Research
  • Cost–utility analysis for platinum-sensitive recurrent ovarian cancer therapy in South Korea: results of the polyethylene glycolated liposomal doxorubicin/carboplatin sequencing model [2013]

• Journal of Gynecologic Oncology
  • Trends in the cost of ovarian cancer across phases of care and surgical years in Korea [2026]
  • Clinical practice guidelines for ovarian cancer: an update to the Korean Society of Gynecologic Oncology guidelines [2025]
  • Clinical guidelines for ovarian cancer: the Korean Society of Gynecologic Oncology guidelines [2024]
  • Cause-specific mortality rate of ovarian cancer in the presence of competing risks of death: a nationwide population-based cohort study [2022]
  • Practice guidelines for management of ovarian cancer in Korea: a Korean Society of Gynecologic Oncology Consensus Statement [2018]
  • Incidence of epithelial ovarian cancer according to histologic subtypes in Korea, 1999 to 2012 [2015]

• Scientific Reports
  • Increased risk of young-onset ovarian cancer in women with non-alcoholic fatty liver disease: A nationwide cohort study of 2.3 million women aged 20-39 years [2025]
  • Nationwide population-based study of prevalence and trend of borderline ovarian tumors in the Republic of Korea [2021]

Saudi Arabia

• PeerJ
  • Knowledge and application of sonographic scoring models for ovarian cancer management among gynecologists in Saudi Arabia: a cross-sectional study [2025]

Singapore

• Annals Academy of Medicine Singapore
  • Singapore Cancer Network (SCAN) Guidelines for Front-Line Systemic Therapy of Newly Diagnosed Advanced Epithelial Ovarian Cancer [2015]

• Asian Pacific Journal of Cancer Prevention
  • Ovarian Cancer Incidence in the Multi-Ethnic Asian City-State of Singapore 1968-2012 [2019]

South Africa

• BMC Cancer
  • Trends in national and ethnic burden of ovarian cancer mortality in South Africa (1999-2018): a population based, age-period-cohort and join point regression analyses [2025]

Spain

• Clinical and Translational Oncology
  • GEICO (Spanish Group for Investigation on Ovarian Cancer) treatment guidelines in ovarian cancer 2012 [2013]

• Journal of Ovarian Research
  • Management of advanced ovarian cancer in Spain: an expert Delphi consensus [2021]

• Sociedad Española de Oncología Médica
  • SEOM-GEICO clinical guideline on epithelial ovarian cancer (2023) [2024]
  • SEOM clinical guideline in ovarian cancer (2020) [2021]
  • Recommendations for biomarker testing in epithelial ovarian cancer: a National Consensus Statement by the Spanish Society of Pathology and the Spanish Society of Medical Oncology [2018]

• Virchows Archiv
  • Mutational Screening of BRCA1/2 Genes as a Predictive Factor for Therapeutic Response in Epithelial Ovarian Cancer: A Consensus Guide from the Spanish Society of Pathology (SEAP-IAP) and the Spanish Society of Human Genetics (AEGH) [2020]

Sri Lanka

• Sri Lanka College of Obstetricians & Gynaecologists
  • Management of epithelial ovarian cancers [2021]

Sweden

• Gynecologic Oncology
  • Primary treatment and survival in malignant ovarian germ cell tumors: A nationwide population-based Swedish Gynecologic Cancer Group (SweGCG) study [2025]
  • Hormone replacement in premenopausal women treated with bilateral oophorectomy for ovarian cancer - a nationwide population-based study [2022]

• International Journal of Cancer
  • Pelvic inflammatory disease and risk of borderline ovarian tumors: A national population-based case-control study in Sweden [2025]

Switzerland

• Swiss Medical Weekly
  • Ovarian cancer in Switzerland: incidence and treatment according to hospital registry data [2018]

Syria

• BMC Cancer
  • Epidemiological and clinicopathological characteristics of ovarian cancer in Syria during the war years: a national multicenter retrospective study (2017-2021) [2025]

Taiwan

• BMC Women's Health
  • Association of pelvic inflammatory disease (PID) with ovarian cancer: a nationwide population-based retrospective cohort study from Taiwan [2021]

• Cancer Medicine
  • Outcomes after fertility-sparing surgery of early-stage ovarian cancer: A nationwide population-based study [2024]

• International Journal of Environmental Research and Public Health
  • Different Influences of Endometriosis and Pelvic Inflammatory Disease on the Occurrence of Ovarian Cancer [2021]

Thailand

• Scientific Reports
  • Cost effectiveness of bevacizumab plus carboplatin paclitaxel versus carboplatin paclitaxel as front line for advanced ovarian cancer in Thailand [2025]

United Kingdom

• BJOG: An International Journal of Obstetrics & Gynaecology
  • The detection of germline and somatic BRCA1/2 genetic variants through parallel testing of patients with high-grade serous ovarian cancer: a national retrospective audit [2022]

• BMC Medicine
  • Cost-effectiveness of screening for ovarian cancer amongst postmenopausal women: a model-based economic evaluation [2016]

• British Gynaecological Cancer Society
  • British Gynaecological Cancer Society/British Association of Gynaecological Pathology consensus for genetic testing in epithelial ovarian cancer in the United Kingdom [2024]
  • British Gynaecological Cancer Society Recommendations for Evidence Based, Population Data Derived Quality Performance Indicators for Ovarian Cancer [2023]

• Cancer Research UK
  • Ovarian cancer statistics

• Future Oncology
  • Current practices for the management of advanced high-grade epithelial ovarian cancer in the UK: OC-NOW survey (2023) [2025]

• Health Technology Assessment
  • Identifying the best diagnostic test for ovarian cancer - synopsis of Refining Ovarian Cancer Test accuracy Scores (ROCkeTS) research [2026]
  • Mortality impact, risks, and benefits of general population screening for ovarian cancer: the UKCTOCS randomised controlled trial [2025]
  • Risk scores to guide referral decisions for people with suspected ovarian cancer in secondary care: a systematic review and cost-effectiveness analysis [2018]

• Journal of Medical Genetics
  • The avoiding late diagnosis of ovarian cancer (ALDO) project; a pilot national surveillance programme for women with pathogenic germline variants in BRCA1 and BRCA2 [2023]

• National Institute for Health and Care Excellence
  • Ovarian cancer: recognition and initial management [2026]
  • Ovarian cancer (Quality standard) [2026]
  • Ovarian cancer: identifying and managing familial and genetic risk [2024]
  • Maximal cytoreductive surgery for advanced ovarian cancer [2023]
  • Bevacizumab with carboplatin, gemcitabine and paclitaxel for treating the first recurrence of platinum-sensitive advanced ovarian cancer (terminated appraisal) [2019]
  • Tests in secondary care to identify people at high risk of ovarian cancer [2017]
  • Topotecan, pegylated liposomal doxorubicin hydrochloride, paclitaxel, trabectedin and gemcitabine for treating recurrent ovarian cancer [2016]
  • Ovarian cancer (advanced): bevacizumab 7.5 mg/kg in combination with paclitaxel and carboplatin for first-line treatment [2013]
  • Bevacizumab in combination with paclitaxel and carboplatin for first-line treatment of advanced ovarian cancer [2013]
  • Bevacizumab in combination with gemcitabine and carboplatin for treating the first recurrence of platinum-sensitive advanced ovarian cancer [2013]
  • Ovarian cancer

• NHS England
  • Clinical commissioning policy: Trametinib in recurrent or progressive low grade serous ovarian cancer (adults) [2023]

• Obstetrician & Gynaecologist
  • Borderline ovarian tumours [2025]

• Public Health Scotland
  • Ovarian cancer

• Royal College of Obstetricians and Gynaecologists
  • The Use of Biomarkers to Stratify Surgical Care in Women with Ovarian Cancer [2022]
  • Risk-Reducing Salpingo-Oophorectomy and the Use of Hormone Replacement Therapy Below the Age of Natural Menopause [2021]
  • Management of Female Malignant Ovarian Germ Cell Tumours [2016]
  • Management of Ascites in Ovarian Cancer Patients [2014]
  • Targeted therapies for the management of ovarian cancer [2013]

• Royal College of Radiologists
  • Recommendations for cross sectional imaging in cancer management, Second edition: Ovarian cancer [2014]

• SIGN
  • Management of epithelial ovarian cancer

• UK National Screening Committee
  • Ovarian cancer

United States

• Agency for Healthcare Research and Quality
  • Screening for Ovarian Cancer [2018]

• American Cancer Society
  • Treating Ovarian Cancer
  • Ovarian Cancer Statistics
  • Ovarian Cancer

• American College of Obstetricians and Gynecologists
  • Opportunistic Salpingectomy as a Strategy for Epithelial Ovarian Cancer Prevention [2019]
  • The Role of the Obstetrician-Gynecologist in the Early Detection of Epithelial Ovarian Cancer in Women at Average Risk [2017]

• American College of Radiology
  • Staging and Follow-Up of Ovarian Cancer
  • Ovarian Cancer Screening

• American Family Physician
  • Diagnosis and Management of Ovarian Cancer [2016]

• American Society of Clinical Oncology
  • Neoadjuvant Chemotherapy for Newly Diagnosed, Advanced Ovarian Cancer: ASCO Guideline Update [2025]
  • Poly(ADP-Ribose) Polymerase Inhibitors in the Management of Ovarian Cancer: ASCO Guideline Rapid Recommendation Update [2022]
  • Assessment of Adult Women With Ovarian Masses and Treatment of Epithelial Ovarian Cancer: ASCO Resource-Stratified Guideline [2021]
  • PARP Inhibitors in the Management of Ovarian Cancer: ASCO Guideline [2020]
  • Germline and Somatic Tumor Testing in Epithelial Ovarian Cancer: ASCO Guideline [2020]

• Annals of Surgical Oncology
  • Is it time to centralize ovarian cancer care in the United States? [2016]

• BMJ Quality & Safety
  • When evidence says no: gynaecologists’ reasons for (not) recommending ineffective ovarian cancer screening [2020]

• CA: A Cancer Journal for Clinicians
  • Ovarian cancer statistics, 2018 [2018]

• Cancer
  • Improving the quality of care for patients with advanced epithelial ovarian cancer: Program components, implementation barriers, and recommendations [2022]
  • The Chicago Consensus on peritoneal surface malignancies: Management of ovarian neoplasms [2020]

• Cancer Epidemiology Biomarkers & Prevention
  • Population Distribution of Lifetime Risk of Ovarian Cancer in the United States [2015]

• Cancer Medicine
  • Oophorectomy-Corrected Ovarian Cancer Incidence, Survival, and Mortality by Subtype, Race, Ethnicity [2026]

• Cancer Research Communications
  • Trends of Ovarian Cancer Incidence by Histotype and Race/Ethnicity in the United States 1992-2019 [2023]

• Centers for Disease Control and Prevention
  • Ovarian Cancer

• Clinical Journal of Oncology Nursing
  • Ovarian Cancer Symptom Clusters: Use of the NIH Symptom Science Model for Precision in Symptom Recognition and Management [2022]

• Environmental Health Perspectives
  • Outdoor Air Pollution Exposure and Ovarian Cancer Incidence in a United States-Wide Prospective Cohort Study [2024]

• Food and Drug Administration
  • FDA Approval Summary: Mirvetuximab Soravtansine-Gynx for FRa-Positive, Platinum-Resistant Ovarian Cancer [2023]
  • FDA Approval Summary: Olaparib Monotherapy in Patients with Deleterious Germline BRCA-Mutated Advanced Ovarian Cancer Treated with Three or More Lines of Chemotherapy [2015]

• Future Oncology
  • Unmet needs and emerging therapeutics in low-grade serous ovarian carcinoma: from chemoresistance to precision medicine [2025]

• Gynecologic Oncology
  • Trends in estimated PARP inhibitor eligibility and benefit among US epithelial ovarian cancer patients [2024]
  • Racial disparities in non-recommendation of adjuvant chemotherapy in stage II-III ovarian cancer [2022]
  • Ovarian cancer in the United States: Contemporary patterns of care associated with improved survival [2014]

• Institute for Clinical and Economic Review
  • Ovarian Cancer

• International Journal of Gynecological Cancer
  • Oncologist perceptions of "cure" and long-term management in advanced ovarian cancer in the United States: results from a cross-sectional survey [2025]
  • Temporal trends of healthcare system use between symptomatic presentation and ovarian cancer diagnosis in the United States [2022]
  • National trends in bowel and upper abdominal procedures in ovarian cancer surgery [2020]

• JAMA Network Open
  • Trends in Primary Treatment and Median Survival Among Women With Advanced-Stage Epithelial Ovarian Cancer in the US From 2004 to 2016 [2020]

• JCO Oncology Practice
  • Risk-Reducing Bilateral Salpingo-Oophorectomy for Ovarian Cancer: A Review and Clinical Guide for Hereditary Predisposition Genes [2022]

• Journal of Comparative Effectiveness Research
  • Use of individualized starting dose and niraparib hematologic adverse event management costs in ovarian cancer [2025]

• Journal of Global Health
  • Epidemiology and risk factors for ovarian cancer incidence in the USA: a multilevel analysis [2025]

• Journal of the National Cancer Institute
  • Disparities in Ovarian Cancer Care Quality and Survival According to Race and Socioeconomic Status [2013]

• Journal of Women's Health
  • Adherence of Primary Care Physicians to Evidence-Based Recommendations to Reduce Ovarian Cancer Mortality [2016]

• M.D. Anderson Cancer Center
  • Ovarian Cancer

• National Academies of Sciences, Engineering, and Medicine
  • Ovarian Cancers: Evolving Paradigms in Research and Care [2016]

• National Cancer Institute
  • State of the Biomarker Science in Ovarian Cancer: A National Cancer Institute Clinical Trials Planning Meeting Report [2022]
  • Ovarian Germ Cell Tumors Treatment (PDQ®)
  • Ovarian Cancer
  • Ovarian Borderline Tumors Treatment (PDQ®)
  • Childhood Ovarian Cancer Treatment (PDQ®)

• National Comprehensive Cancer Network
  • NCCN Guidelines® Insights: Ovarian Cancer, Version 3.2022 [2022]
  • Ovarian Cancer, Version 2.2020, NCCN Clinical Practice Guidelines in Oncology [2021]

• Obstetrics & Gynecology
  • Trends in Location of Death for Individuals With Ovarian Cancer in the United States [2024]
  • Health Disparities in Ovarian Cancer: Report From the Ovarian Cancer Evidence Review Conference [2023]
  • Executive Summary of the Ovarian Cancer Evidence Review Conference [2023]
  • Trends in Relative Survival for Ovarian Cancer From 1975 to 2011 [2015]
  • Racial Disparities in the Treatment of Advanced Epithelial Ovarian Cancer [2013]

• OncoLink
  • Ovarian Cancer

• PLoS ONE
  • Trends in extent of surgical cytoreduction for patients with ovarian cancer [2021]

• Society of Gynecologic Oncology
  • Society of Gynecologic Oncology Journal Club: Controversial conversations in gynecologic cancer - Navigating maintenance therapy for homologous recombinant proficient ovarian cancer [2022]
  • FDA ovarian cancer clinical trial endpoints workshop: A Society of Gynecologic Oncology White Paper [2017]
  • Neoadjuvant Chemotherapy for Newly Diagnosed, Advanced Ovarian Cancer: Society of Gynecologic Oncology and American Society of Clinical Oncology Clinical Practice Guideline [2016]
  • Society of Gynecologic Oncology recommendations for the prevention of ovarian cancer [2015]
  • SGO guidance document for clinical trial designs in ovarian cancer: A changing paradigm [2014]
  • SGO Clinical Practice Statement: Genetic Testing for Ovarian Cancer [2014]
  • Ovarian cancer clinical trial endpoints: Society of Gynecologic Oncology white paper [2014]
  • SGO Clinical Practice Statement: Salpingectomy for Ovarian Cancer Prevention [2013]

• StatPearls
  • Epithelial Ovarian Cancer

• U.S. Preventive Services Task Force
  • Ovarian Cancer: Screening [2018]

WHO

• International Agency for Research on Cancer
  • Ovary
  • Ovarian cancer

• World Health Organization
  • Ovary cancer

{Related topics}

• Topic
  • Ovarian, fallopian tube, and primary peritoneal cancers
  • Gynecologic oncology